Académique Documents
Professionnel Documents
Culture Documents
30th ANNIVERSA
WINTER 2014
SBRT: Radiation therapy cuts treatment times by a third WHOLE PACKAGE: Healing the complete self
RESEARCH ROCKSTAR: Dr. Gregory Cairncross tackles brain cancer head on
LOFTY GOAL: Worlds Longest Hockey Game
PLUS: Give speed skating a whirl; integrative palliative care and more
PM#40020055
CONQUERCANCER.CA
888 624 BIKE [2453]
TITLE PARTNER
PRESENTED BY
CONTENTS
COVER STORY: Celebrating 30 years of progress in cancer
treatment and research.
WINTER SPOTLIGHT
30 YEARS OF CANCER RESEARCH
IN ALBERTA
38
20
18
DEPARTMENTS
4 OUR LEAP
6
26
46
11
12
FOREFRONT
Firefighters join the Tomorrow Project; Brain
cancer treatment heads to clinical trial; Easy
stuffed chicken breast and more
NEXT GEN
Keith Brown meets the recipient of a studentship
created in his mothers name
BODY MIND
Growing support for the whole cancer patient
13 SMART EATS
14
50
16
PATIENT ENGAGEMENT
Patient-centred care starts with a small gesture
44 CORPORATE GIVING
50 MY LEAP
FEATURES
30 GREAT EXPECTATIONS
35 SPINNING CIRCLES
42 WHY I DONATE
A MATTER OF TIME
38
TOP JOB
Cross Cancer Institute nurse Karey McCann
gives one-of-a-kind care
46 RESEARCH ROCKSTAR
winter 2014
TRUSTEES
Angela Boehm, Chair
Calgary
Gary Bugeaud
Calgary
Steven Dyck
Lethbridge
Paul Grundy
Edmonton (ex-officio)
Jordan Hokanson
Edmonton
Don Lowry
Edmonton
Katie McLean
Calgary
John J. McDonald
Edmonton
Andrea McManus
Calgary
Brent Saik, Vice Chair
Sherwood Park
Sandy Slator
Edmonton
Greg Tisdale
Calgary
Cancer has been around since the dawn of history. Some of the earliest
evidence of the disease is found among fossilized bone tumours, human
mummies and ancient manuscripts. The first description of cancer
although it was not named that was in Egypt, dating back to about
3000 BC. An early textbook on trauma surgery describes eight tumours
or ulcers of the breast that were removed by cauterization with a tool
called the fire drill. The description said simply: There is no treatment. And the causes were a mystery, but ancient Egyptians blamed
cancers on the gods.
What a difference a few thousand years makes. Over the last few
centuries, scientists began to develop greater understanding of the
human body. The introduction of tools like the modern microscope
allowed the study of the disease at a cellular level. By the middle of the
20th century, the discovery of the chemical structure of DNA allowed
scientists to understand how genes work and how they could be
damaged by mutations.
Fast forward to the present. It has been well said that scientists have
learned more about cancer in the last two decades than has been
learned in all the centuries preceding. Scientists today are standing on
the shoulders of everyone that has come before them, and while we still
have much to learn, weve come a long way.
At the Alberta Cancer Foundation, we havent been
Now, more than ever, is the
around as long as early Egyptians, but with the celebratime to be bold and do
tion of our 30th anniversary, we have been instrumental
something about cancer.
to many improvements in cancer research, treatment
and care in Alberta. In this issue of Leap youll read
about some of those advancements and hear from patients who have
experienced first-hand how much their lives have improved because
of them.
The Alberta Cancer Foundation has played a role in improving
Albertas cancer survival rates significantly every year over the last few
decades and we will make sure those numbers continue to rise. While
we celebrate the years of research that have brought us to this point,
where more than 100,000 Albertans are alive today after a cancer
diagnosis, the work we do today is crucial to bringing us the next
advancements that will save even more lives.
We believe Albertas cancer program can be among the best in the
world and with our donors continued support, we can make that happen. We are investing in innovative solutions that are vital to translating
research into life-saving therapies. We are thinking outside of the box to
find those big, transformative ideas to make sure something good
comes out of our donors investments. We push discoveries forward
through strategic investments in cancer research that deliver clear
results to patients. Now, more than ever, is the time to be bold and
do something about cancer. So while we are celebrating our 30th anniversary, we know we are on the brink of bigger and better things that will
improve the lives of Albertans facing cancer. Stay tuned.
Myka Osinchuk, CEO
Alberta Cancer Foundation
winter 2014
myleapmagazine.ca
TOGETHER
WERE CREATING
MORE MOMENTS
FOR ALBERTANS
FACING CANCER
Sparking Participation
The Calgary Fire Department throws its weight behind the Tomorrow Project
The Calgary Fire Department has issued a
Tackling Glioblastoma
A new brain cancer therapy heads to clinical trial
In October, we learned that researchers at
winter 2014
myleapmagazine.ca
Cool Runnings
From mushing to ice angling, theres lots to see
and do around Alberta this winter
winter 2014
up and get the event off to a great start this year participants can expect a secret
local guest, according to Kraus. Registration is now open for Bust a Move for Breast
Health 2015. For more information, visit albertacancer.ca/BaMEdmonton2015.
winter 2014
myleapmagazine.ca
INGREDIENTS:
DIRECTIONS:
that shows how cancer cells form tentacles to move from one part of the body
to another. The teams finding could open up new possibilities surrounding the
treatment of cancer.
Since the spread, or metastasis, of cancer is what makes it deadly, we have
been interested for some time in what genes and proteins are required for cells
to proceed through each step, says Lewis, who is also the Alberta Cancer
Foundations Frank and Carla Sojonky Chair in Prostate Cancer Research.
Almost immediately, we saw that the cancer cells moving through the bloodstream were forming long tentacles just before they escaped, so we decided to
take a closer look to see what they were.
Its an exciting find for the team. This means that cancer cell tentacles could
be a promising target for new anti-cancer or anti-metastasis drugs, says Lewis.
During the research, Lewis and his team watched as a cancer cell reached a tentacle slowly out of the bloodstream. Now that the team has identified the process, the researchers can focus on an effort to develop new drugs that could
block the tentacles and improve the lives of cancer patients in the future.
winter 2014
research lab in the Cross Cancer Institute, where comPROUD SON: Keith Brown, shown here in an
puters occupy enough space to make it cramped for
undated photo with his late mother Betty Brown
our small group. Jiali Luan sits down in front of a comon a walk with the family dogs, has created a
studentship in her honour.
puter screen and explains what hes been working on
under Godbouts supervision; wrapping up his fourmonth studentship, he recently gave a presentation of
his research on the enzyme DDX1, a family of proteins
that participates in DNA repair. As the beneficiary of
the Alberta Cancer Foundations 2014 Betty K. Brown
Summer Studentship, Luan is conferred a special privilege today our groups most enthusiastic member,
Keith Brown, established the very studentship Luan
has been working under.
Jane Weller, development director at the Alberta
Cancer Foundation, gives our group a tour of the facility,
and Brown is quick to ask both Godbout and Luan
detailed questions about their findings. Its unfortunate you didnt go into research, Godbout tells Brown.
You think like a scientist. Naming the studentship
after his mother, whose first occurrence of breast cancer was in 1965, Brown stipulated only that the research
be pertinent to patients currently under treatment. I
wanted to give hope to patients that would otherwise
have none at all, he says. Brown established a different
studentship under his fathers name (Dr. Gordon Brown,
who was voted one of Albertas top 100 physicians in
2005) which has been offered since 1984, so he knew
the benefits. Today, however, he gets to see the effects
of the studentship he created in honour of his mother,
and hes overjoyed.
coming through, over and over the most impact you can make in cancer research
Over the summer, Godbout and Luan studied the is in the trainee awards, the graduate programs and the fellowships, she says. For
the future of the Alberta Cancer Foundations fundraiscorrelation between
ing, this is a priority. Students are the fuel for the research
overexpression of DDX1
I wanted to give hope to
and early relapse in
patients that would otherwise have engine. Godbout backs her up, praising the passion and
enthusiasm of the summer students, who need a GPA of
breast cancer patients.
none at all, says Keith Brown.
3.9 or 4.0 to even be eligible to receive the funding. As a
We want to understand
result, The calibre of students is incredible, she says.
what DDX1 does so we
can use different ways of targeting it and see if that can And a lot of them will be interested in medical school because they have the
be used as a method of treatment, Godbout says. If grades for it. These programs also kindle an interest in research, which increases
its just a matter of killing cancer cells, thats easy the the likelihood of important collaborations and discoveries down the road.
Not to put pressure on Luan, though he clearly thrives in the face of challenge.
key is that if you kill cancer cells, you kill normal cells
also. We need to become very clever at identifying tar- He was born in northeast China and came to Edmonton in 2000, and aspires to be
geted approaches. She and Luan both see the the first doctor in his family. Hes engaged in his work and recommends the experiresearch as having wide-ranging implications for treat- ence of being a summer student. Id do it again, he says. Its a great program.
As Godbout heaps compliments on Luans work ethic, its evident that Brown is
ment of all kinds of cancers.
As the tour ends, Weller describes how she and glad to have Luan as a beneficiary. Everyone involved in the studentship is excited
Brown consulted with doctors to create the Alberta to see the project continue and happy to be part of the Brown familys legacy.
Cancer Foundation studentship. The message keeps Today was a good day, says Brown, as he shakes Luans hand.
Alber ta Cancer Foundation
winter 2014
11
BY LINDA E. CARLSON
winter 2014
Heart Health:
Then and Now
winter 2014
13
KNOWLEDGE
IS POWER
winter 2014
winter 2014
15
winter 2014
being clamped down onto the table, for the whirring sound of the equipment, and for the
disembodied, distant voice on the intercom telling me what was going to happen next. No
one else can be in the radiation therapy room with you in the few short minutes it takes for
the treatment to occur. No one can sit there beside you and hold your hand.
And as I sat in the waiting room, sinking deeper into my chair and deeper into my sadness, I felt a hand on my shoulder. A hand reached out and touched me. And that brief
touch told me that I was seen. That human contact told me that my suffering was visible and acknowledged. That warm palm and those five fingers on my shoulder said that
I was not alone and that there was some level of understanding between us, that what
I was experiencing was truly scary and difficult. That touch was encouragement, hope
and compassion.
I looked up to see my radiation therapist. I think, maybe, I managed to smile. I know that
she did.
It is important to be seen, to have our experiences witnessed by others, to know that we
do not suffer alone. Shared by Cheryl H., patient advisor, Calgary Cancer Project Patient and Family Advisory Council
I bet that radiation therapist touches and smiles at her patients every day.
It was not an extraordinary act. She may not even remember doing it. And she may
never fully know the impact of these small moments, or her impact on that patient.
I think all of us are change agents and, when we shift our perspective to acknowledge the power of the small, simple moments, we can create with each other, then
we really do have the power to change the world.
Jessica Dollard is the patient-centred experience advisor on the Calgary Cancer Project. As a
consultant in engagement and patient experience, as well as an actor, film and theatre producer,
programmer, medical skills trainer and executive certified coach, she brings a creative background
to this work.
myleapmagazine.ca
SPECIAL REPORT:
30 YEARS OF PROGRESS
hirty years ago, cancer was a topic that patients and their families
shied away from talking about, not to mention a disease that was far more often
than not a death sentence. Now, on the 30th anniversary of the Alberta Cancer
Foundation, Leap examines the strides that have been made in cancer research,
treatment, drugs and survival rates since 1984, and where we are headed in the future.
18
24
A MATTER OF TIME
Scientific advancements have changed how
we diagnose and treat multiple myeloma
20
26
winter 2014
17
30 YEARS of progress
18
winter 2014
Now, says Venner, we can run a whole genome comprised of millions of genes in a week for under $1,000,
and we can even do some of that work in Alberta. DNA
mapping helps with myeloma because it paints a very detailed picture of what is going on in the cancer cells. You
can sequence all the DNA in a malignancy to see what
genes have changed, what genes are overactive or underactive, he says, noting that DNA changes are what causes
cancer in the first place.
The holy grail, says Venner, is to be able to pinpoint
the driver mutations, multiple DNA changes that can
cause myeloma, and to try to find a drug to turn that off.
He says thats the goal for all cancers, not just myeloma.
A province-wide clinical database, created with funding from the Alberta Cancer Foundation, is another important advancement. A database that tracks patient
treatment and outcomes is the only way you can see
whether what youre doing is working, says Venner. It is
also crucial to put the laboratory findings into perspective, making the discoveries relevant to the patients
sitting in front of us. Before the online database, a doctor would have to sift through paper copies of charts of
other patients to see if a particular drug or combination
had been attempted before. Its the first of its kind for
myeloma in Alberta and will complement other national
and international initiatives. While it may be ambitious,
the ultimate goal is to develop a comprehensive diseasespecific database used by all interested researchers and
clinicians across the country. Venner says that, Given
the interested and experienced core group of people in
Alberta, we are poised to be leaders here.
So far, everything looks good for Dalrymple. Her cancer is back in remission and shes taking oral chemotherapy every day. She knows her remission is temporary, but
shes confident that by the time the myeloma protein level starts to rise in her blood, there will be a new treatment
that will hold the cancer at bay or maybe even cure it .
winter 2014
19
30 YEARS of progress
20
winter 2014
myleapmagazine.ca
LEAPS
& Bounds
Cancer treatment in Alberta has improved
drastically over the last three decades
BY CAITLIN CRAWSHAW
ets imagine you could turn the clock back to 1984 and peek into an oncologists
waiting room. Youd see patients with big hair and shoulder pads, looking
at magazines instead of smartphones. At the front of the room, youd see a
receptionist typing away on the latest and greatest computer technology: an Apple IIe. You
might hear Duran Duran playing on the radio. But you wouldnt hear anyone being scheduled
for an MRI, laparoscopic surgery or even a biopsy, and its unlikely youd see a patient smiling
after a test result. In fact, if you came back week after week, youd stop recognizing the
patients. Thats because, 30 years ago, practically everything to do with cancer treatment
from diagnosis to surgery to chemotherapy was on the verge of a revolution.
As a result of major improvements in diagnosis and treatment, patient outcomes have
drastically improved, says Dr. Peter Venner, former director of medical oncology at the Cross
Cancer Institute. When he began practising medicine in 1980, a man with prostate cancer (his
treatment specialty) would have been treated with hormone therapy and expected to live just
two years. Now, it is probably beyond five years because of new treatments, he says.
In fact, almost every cancer you can think of including breast, lung, colorectal
and gynecological cancers have much higher survival rates these days. Part of this relates to
better, earlier diagnosis, so theres better screening taking place, but theres also better
treatment, Venner says.
winter 2014
21
30 YEARS of progress
SLICE OF LIFE: Advancements in technology over
the past three decades have meant that survival rates
for certain cancers, such as Dr. Peter Venners treatment
specialty, prostate cancer, are much higher.
Diagnosis
location of a tumour and guide procedures like surgery, biopsy and radiation
In the early 1980s, a patient with cancer symptoms therapy. The device uses computing technology to analyze a series of X-ray
would have approached his family doctor with a health views of the body, taken at different angles, to create cross-sectional images. A
complaint, just like today but the similarities in few years after that, magnetic resonance imaging (MRI) a device that involves
treatment would have ended there. Instead of being magnetic fields and radio waves became ubiquitous, allowing doctors to get an
sent for an MRI or CT scan
even clearer view of a
to look for signs of cancer, a
patients internal organs,
You could almost count on your hand the
patient would have been sent
especially the brain and
number of drugs available to cancer patients spinal cord.
for an X-ray one of the only
imaging techniques available,
In the mid-1990s, positron
in the 70s and 80s. Now, there are probably
offering only a very basic view
emission
tomography (PET)
100, says Dr. Claire Temple-Oberle, a
of the inside of a persons body.
scanning became routine,
surgeon with the Tom Baker Cancer Centre. but it didnt come to Alberta
Ultrasound technology which
offers a clearer view of the bodys
until 2002. This screening
tissues without the radiation of an X-ray was still in its tool requires patients to swallow, inhale or be injected with a radioactive drug that
infancy and wasnt in common use for many more years. allows the device to capture information about chemical activity in the body. Its a
All the tools we take for absolute granted now were just useful tool for diagnosing some cancers.
not available, says Dr. Sandy McEwan, former director,
A big reason for the advancement in these technologies is computing power, which
oncologic imaging at the Cross Cancer Institute.
has improved immeasurably over the years, says Venner. As a result, doctors can get to
He explains that it wasnt until the middle of the bottom of a patients complaint much faster than ever before. We can diagnose
the 80s that computerized tomography (CT) cancer earlier and find metastatic spread earlier, he says. Imaging technologies also
scans began to be used consistently, offering help clinicians conduct a biopsy, in which a portion of tissue is removed and examined
doctors a tool to more accurately pinpoint the under a microscope for signs of cancer. All of this has improved patient outcomes.
22
winter 2014
myleapmagazine.ca
winter 2014
23
1984: Planning
starts for the Human
Genome Project,
the worlds largest
collaborative
biological project.
1986: Breast
cancer mortality
rates in Canada are
at their highest. They
have decreased by 42
per cent since then as
a result of increased
and better screening
technologies and
treatments.
1998: Results
from the National
Cancer Institutesponsored Breast
Cancer Prevention
Trial show that the
drug tamoxifen
reduces the incidence of breast
cancer among
women at increased
risk of the disease by
about 50 per cent.
1998: Research
2003: The
Human Genome
Project is considered
complete, helping
scientists understand diseases at a
whole new level.
2008-2010:
2008: Alberta
offers the human
papilloma virus
(HPV) vaccine to
Grade 5 girls. The
HPV viruses can
cause cervical, head
and neck, anal and
penile cancers and
genital warts.
2008-2010:
2010: Patient
2010: Albertas
population grows
to 3.8 million, up 46
per cent since 1990.
1990: Albertas
population reaches
2.6 million.
1994: The
By the NumBers
A male born in Alberta is more
likely to develop prostate
cancer (with a rate of 1 in 6)
than lung cancer (1 in 12).
A woman born in Alberta is
more likely to develop breast
cancer (with a rate of 1 in 8)
than lung cancer (1 in 14).
About 1 in 2 Albertans will
develop cancer in his or her
lifetime and 1 in 4 people born
in Alberta will die from cancer.
24
winter 2014
myleapmagazine.ca
A CAnCer Story
BY MARGARET VERNICK
2014: Alberta
expands its HPV
vaccines to boys in
Grades 5 and 9.
2013: Breast
brachytherapy is
performed for the
first time in Alberta.
2010: Breast,
2010: 15,232
people are
diagnosed with
cancer in Alberta;
5,526 Albertans die
from the disease.
Twenty-seven per
cent of all deaths in
Alberta in 2010 were
attributable to cancer.
2030: Albertas
population is
expected to reach
five million people.
winter 2014
25
Healing the
Whole Self
26
winter 2014
myleapmagazine.ca
programs to help people at any point in their cancer journey (Wellspring does not offer
clinical or research services, but works very closely with colleagues in the community who
do.) Our diverse group of offerings speak to body, mind and spirit, says Patti Morris, who
has served as executive director of Wellspring since its inception in 2006. Wellspring is
also a community, a welcoming space, where people living with cancer can be with others
who get it. Programs dubbed Brain Fog, Exercise and Educate, and Creative Journaling
empower and build confidence so people diagnosed with cancer as well as their families
can make a positive difference in their lives.
It also offers a library, child-minding service, the previously mentioned peer support program and a stream of services specific to young adults who are living with
cancer. Services are free and do not require a referral. There are more than 2,700
members at Wellspring, which offers over 20,000 hours of programming every year.
Treating the whole person is vitally important for enhanced quality of life, Morris
says, adding that the need for this kind of approach is growing, as more people are
diagnosed with cancer and live longer with the disease. Not attending to symptoms
of distress can not only make a complicated cancer journey that much more difficult
for people, but can overtax an already-strained medical system if patients seek out
support in a reactive way.
No one knows this better than Dr. Barry Bultz, director of the Department of Psychosocial Resources at the Tom Baker Cancer Centre. He is a leader in psychosocial oncology and is passionate about the importance of tackling what is now referred to as the sixth
vital sign (behind blood pressure, temperature, heart rate, pulse and pain) distress.
Cancer is a challenging disease, he says, involving complexities of diagnosis, treatment, recurrence of disease, survivorship and palliative care. The primary goal of cancer
treatment is remission or, ideally, a cure, but if thats not to be, the goal becomes helping
the patient adjust to living with a life-threatening disease. How can they be comfortable,
cope with the stress associated with physical, psychosocial and practical manifestations
of the disease, decrease burden and suffering, resume a healthy quality of life and facilitate a good death through resolution of existential issues? In other words, it is about
reducing distress surrounding the overall cancer experience.
The Screening for Distress (SFD) tool, used in Alberta and eight other provinces,
tracks and treats distress associated with the cancer experience. Developed at the
Tom Baker Cancer Centre with funds from the Alberta Cancer Foundation, SFD is a
one-page questionnaire listing 10 questions and a well-being checklist, designed to
track a patients distress levels in a variety of areas repeatedly over the cancer journey.
It is used by the health-care team to identify and gauge what is bothering a patient, so
that clinical responses can be timely and tailored. If we dont measure these things,
we cant treat them, he says.
Linda Hack
winter 2014
27
albertacancer.ca/ringettescores2015
continues to use the tools she has sought out to keep her moving in the right direction,
and is seeking out new ways to live as vibrantly and functionally as possible. And she
has advice for others: Life throws random curveballs. You really dont know what is
around the corner, she says. Dont take the present for granted. Try to be fully present and in the moment.
SPRING 2015
SPRINT TRIATHLON
AND DUATHLON
Get inspired. Register now.
albertacancer.ca/joesteam
30
winter 2014
myleapmagazine.ca
Great
Expectations
BY SAMUS SMYTH / PHOTO BY BRIAN BRADY
adical improvements in radiation therapy have drastically of the liver and spine. Clinical studies are starting to
look at treating these other sites with SBRT. With Alberta
shortened the number of sessions required for lung cancer patients.
Stereotactic body radiation therapy (SBRT) delivers a higher dose of Cancer Foundation donor support, they have committed
radiation over a more condensed period of time, cutting treatment to expanding to these sites that were previously not treatduration by a third. The high-dose radiation isolates tumours in the body over a shorter ed, says Gabos. It has been very successful in lungs and
course of treatment, with fewer side effects than currently experienced with conven- we are trying to move this success to other areas.
The therapys achievetional radiation treatment.
ments
have in part been due
Prior to the introduction of SBRT, therapy
With SBRT, more lung cancer patients are
to the assistance of a numfor lung cancer patients often took between
living longer and we are clearing more lung ber of donors across the
four to seven weeks, or upwards of 30 visits.
cancers compared to conventional therapy, province.
That has since dropped to between four and
Donors have been instrufive weeks and fewer visits.
says Dr. Zsolt Gabos.
mental in supporting enhanced
The procedure was introduced at the
Cross Cancer Institute in 2010, and SBRT has since become the standard treament for care grants to fund the necessary technologies that will
men and women with inoperable lung cancer since. Its used on patients with clinical help move us to be able to conduct this therapy in the
liver or spine, which require specialized equipment that
early-stage cancer, with tumours measuring as large as seven centimetres.
The treatment has been so successful that they are looking to make room for the we did not have available, says Gabos.
With great success comes great expectation. Gabos
procedure at the Central Alberta Cancer Centre and the Jack Ady Cancer Centre
cautions that not all cancer patients are a right fit to rein Lethbridge.
The process begins like a traditional consultation. A number of scans are taken to ceive SBRT. Treatments are part of an individualized
determine the exact location of the tumour and how much it moves with the individ- treatment plan, and there are many factors that go into
uals body. A four-dimensional scan is used for the lung and liver for an even higher these decisions, he says. [For] something like the livlevel of precision. A specialized robotic couch is then used to perfectly position a er, location matters, and it really is sort of personalized
treatment for the specific scenario. People wish to know
patient for pinpoint radiation treatment.
A main concern with traditional treatment is that patients with emphysema, or ad- if they are eligible, but cancer is so diverse. This has the
verse chronic obstructive pulmonary disease (COPD), are not eligible for lung cancer chance to treat many patients, but to be able to decide
treatment or surgery. Both health issues are common in patients with lung cancer. who is appropriate is a multi-step process.
Gabos says the success rate of controlling the localBut with this modern upgrading, patients with both conditions can now be treated
ized disease in lung cancer patients is 90 per cent. Aleffectively.
Side effects are significantly less with SBRT than with conventional therapy, says though he is hesitant to assume that the success rate
would transfer to other parts of the body, he remains
Dr. Zsolt Gabos of the Cross Cancer Institutes radiation oncology department.
Sterotactic radiation was originally invented for the treatment of tumours in the optimistic about the evolution of SBRT.
We are confident. We do not know if it can be as high,
brain. But in the past decade the treatment has evolved to attack tumours in the lungs,
but we are hoping to see considerably better results
thus adding the word body to the title.
Raja Mita, director of program investments at the Alberta Cancer Foundation, says than conventional radiation therapy, he says.
Long-term improvements will depend on the
one of the ultimate goals of provincial health care is to ensure that every Albertan has
access to the same aid. He commended the work of Gabos and his colleagues, noting success of the clinical trials, but hopefully similar to what
that advances in their work and research indicate that SBRT could be used to treat we have seen in the lungs. With SBRT, more lung cancer
patients are living longer and we are curing more lung
tumours across the body.
This work could cement and provide the evidence to begin implementing this cancers compared to conventional therapy, he continues.
Trials for new sites could begin as early as 2015, with
therapy province-wide, says Mita.
The treatment gives new promise to difficult-to-treat localized cancers like those liver patients among the first to try it.
Alber ta Cancer Foundation
winter 2014
31
32
winter 2014
myleapmagazine.ca
Bridging
THE GAP
Integrating a palliative care approach within cancer care
BY SUE LEBRETON
t times, it can seem that cancer is with cancer for several years, remembers the first time
surrounded by powerful words and strong she heard the term palliative in relation to her care, in
language. But one word thats hard to come to 2009. As I woke up from a surgical procedure, the nurse
terms with is palliative. For many, it implies co-ordinator told me I was being referred to the palliative
the end of life, surrender. Its a word that individuals living home-care team. I recall how frightening that was. No one
with cancer, their families and their health-care teams, had told me that I was dying. The palliative care team was
uniquely qualified to deal with a case as complex as Campstruggle to raise in conversation.
Yet its a word and a conversation that are essential to bells. I needed that specialized care but my goal was to
those whose cancer continues to advance and requires recover, she says. Recover she did. That word, palliative,
is loaded emotionally and
complex medical care, and
for those who are facing the Make sure that the patient has family, for most patients and famend of their life. According friends or a health-care support worker ilies, it indicates that their
one is dying, she says.
to the World Health Orgawith them when bad news is delivered loved
To her way of thinking,
nization, palliative care is
a dimension of care that so that the diagnosis can be processed the word palliative covers
intricate cancer care on a
improves the quality of life
together, says Alice Campbell.
spectrum, including people
of patients and their families facing the problems associated with life-threatening who will graduate from care and those who are terminally
illness, through the prevention and relief of suffering by ill and will progress toward the end of life with the support
means of early identification and impeccable assessment of a palliative team the entire way. When she was diagand treatment of pain and other problems, physical, psy- nosed with stage four non-Hodgkins lymphoma in 2009,
Campbells doctor told her there was no cure. Its a very
chosocial and spiritual.
While the definition of palliative care is supportive, in hard conversation when your doctor says, This cancers
reality few of us are ever prepared to hear that our life will not going away. You can count on it coming back but when
end, says Bert Enns, a spiritual care specialist and project it does hopefully we will have a new treatment. With the
lead at the Tom Baker Cancer Centre and Calgary Zone most recent reoccurrence, Campbell was told she could
Palliative Care Collaborative. Life is precious. As health- access palliative care again, if and when she needs it.
With years of nursing behind her, as well as her own
care providers, we face a dilemma. How can we explore
palliative and end-of-life care in a gentle and timely way cancer experiences, Campbell felt she had something to
to ensure that people have the necessary support through offer the Tom Baker Cancer Centre and the Calgary Zone
Palliative Care Collaborative. Ive learned a thing or two
one of lifes most challenging transitions?
Alice Campbell, a retired nurse who has been living after being around Tom Baker for so long and caring for
winter 2014
33
very sick adults and kids. Death is not the worst thing that
can happen to people, she says. She has some suggestions
for health-care professionals: Give bad news in small, digestible amounts where possible, so that there is time to
adjust. Make sure that the patient has family, friends or a
health-care support worker with them when bad news is
delivered so that the diagnosis can be processed together.
According to Enns, recent research has identified the
benefits of an early palliative approach. By working with
individuals and their families, health-care professionals
can help patients access a multitude of services for their
physical, emotional and spiritual well-being. With this
support, patients can make decisions that reflect their values and personal goals for living with cancer, including the
last stretch of life. For example, incorporating a palliative
approach into care can ensure that quality of life issues are
integrated into discussions regarding treatments at the
point of diagnosis. If treatments are not successful and
cancer advances, appropriate supports are added to ensure symptoms are well managed and decisions regarding
treatments continue to reflect an individuals priorities filled place for people with compromised immune systems, but its also an expensive way
and values. Patients need to be well informed about treat- to offer care that could be provided at home, especially if palliative care were involved.
ment options and services available at all points of their Once we had a palliative home-care nurse supporting us at home, we would never have
needed an ER visit, says Erlendson. We should have been in palliative care before
journey with cancer.
Enns is leading a two-year project, funded by the we were.
Although essential for Erlendson and his family, this care was not easy to access.
Alberta Cancer Foundation, to enhance the care for Tom
Baker Cancer Centre patients and their families in the There were many positives about Marjs experiences with the Tom Baker. The key meetings were well handled and we never felt rushed, he says.
Calgary Zone. The project
Despite Calgary having one of the
Erlendson even speaks positively about the chemo unit:
examines current services
best-resourced and utilized palliative We both really liked it. It was a happy and upbeat place.
and identifies gaps and opBut the transition from independence to dependence
portunities for best praccare programs in the country, there is
did not go as well. From the moment of Marjs diagnotices required to integrate
recognition that cancer patients and sis, the family knew her cancer was terminal. There was
an early palliative approach
their families are not always accessing something that should have kicked in so that palliative
to care. Despite Calgary
home care would have come to us. In retrospect we see
having one of the best-rethese services in a timely manner.
this, he says. Only because Erlendson had some prior
sourced and utilized palliative care programs in the country, there is recognition that knowledge of palliative home care gained from a neighbour, and through his communicacancer patients and their families are not always accessing tions work, did he realize that Marj required this service.
So he picked up the phone. Though he was told he could not self-refer, he stayed on the
these services in a timely manner.
In Phase 2 of the project, the committee will develop phone until he got a yes. Hes not optimistic that the average Albertan would have been so
pathways that guide patients, families and health-care lucky. Nobody referred us to palliative home care. We fell through the cracks.
Although they were a family who had fallen into a gap in the transition phase of care,
teams to ensure these conversations about care decisions
and resources are proactive and enhance the integration once they accessed palliative care, their experience transformed. There are no words
of palliative services. To better integrate early access to to describe the giftedness of that home-care nurse. She met my wife spirit-to-spirit,
palliative care, the committee will develop pilot opportu- Erlendson says. The nurse also interacted with Erlendson and his then-21-year-old son in
nities to address current gaps. It will also develop educa- different but equally amazing ways.
Palliative home care provided services that greatly reduced the burden of care on Ertional resources that support health-care professionals to
lendson and his family. For example, they connected the family with a pharmacy that dehave these difficult early conversations.
The Tom Baker Cancer Centre and Calgary Zone livered medications. This was a huge time and energy saver because Marjs medications
Palliative Care Collaborative will review services used could change every few days.
Erlendsons motivation for joining the project is a hope to be heard by policy-makers.
by more than 1,900 Calgarians who died from cancer
in 2012. By reviewing this data, the project committee People want to die at home, he says. They do not want to die in hospital. Marjs palliwill better understand how earlier conversations about ative home-care nurse was with her when she passed away. It may sound odd, but I refer
palliative care may impact overall support for patients in to Marjs last weeks and days as beautiful. It was beautiful caring from a gifted home-care
their last months of life including the need to use emer- nurse. Imagine if we had never accessed that gift? It would have been an awfully dark experience, says Erlendson.
gency or acute care services.
The challenge is clear. Whats the best way to introduce palliative care to ensure its enLike many families coping with advanced stages of cancer, Richard Erlendson, a communications professor at tire scope is provided? Is it a term that can become acceptable and supportive without diMount Royal University, and his wife Marjory, who was minishing a patients sense of hope?
We recognize we have work to do and are committed to finding better ways to intediagnosed with peritoneal cancer, visited the emergency
room on multiple occasions. Not only is this a risky, germ- grate an early palliative care approach into all aspects of our cancer care, says Enns.
34
winter 2014
myleapmagazine.ca
SPINNING
CIRCLES
winter 2014
35
Safety on Ice
Heres the gear youll need to stay safe
on the track:
Speed skates often you can rent these
from the venue or association, until youre
comfortable enough to get your own
Helmet
Leather gloves, to protect your fingers
(Any sort of cut resistant gloves will do.)
More advanced skaters will need cut-resistant
Kevlar protection for their ankles
For short track skating, youll need:
Knee pads
Shin pads
Neck guard
Protective eyewear
36
winter 2014
myleapmagazine.ca
CSSA who become active in speed skating often get together throughout the summer as well, to partake in dry
land training at the citys Edworthy Park. In fact, a lot of
athletes use speed skating as part of their cross-training
plan for participating in other sports. Its a sport thats
complete and healthy and peaceful, says Pacanins. Its
just you, the ice and the timer.
Provincial cool
Here are some venues in Alberta, where you
can take on speed skating:
CALGARY: The Calgary Speed Skating
Association uses the University of Calgarys
Olympic Oval. Email calspeed@ucalgary.ca
to reserve a drop-in spot.
CANMORE: The Banff/Canmore Speed
Skating Club train at the Canmore
Recreation Centre. For more information,
visit www.banffcanmorespeedskating.ca
EDMONTON: Soon, Edmonton will be
home to a new facility, the Aspen Overpass.
The recreation pavilion will be a new home for
the Edmonton Speed Skating Association.
RED DEER: The Red Deer Central Lions
Speed Skating Club is a community club that
practises on the Red Deer Outdoor Oval.
For the past four years, they have held a day
of outdoor competitions on the rink. More
information at: www.reddeerspeedskating.com
SYLVAN LAKE: The Sylvan Lake Ice
Marathon is held every year in February,
and is organized by the Foothills Speed
Skating Marathon Association. Email
contactus@sylvanlakeicemarathon.com
for more information.
winter 2014
37
Top Job
38
winter 2014
myleapmagazine.ca
Command
CENTRAL
The Cross Cancer Institutes Karey McCann has
been recognized for her dedication to patient
education and one-of-a-kind care
BY LUCY HAINES
winter 2014
39
Top Job
s one of only two Canadian sites offering radioisotope ing, Monday through Friday schedule, but she says its a position with
therapy to those diagnosed with neuroendocrine tumours, challenges far beyond the everyday. Nursing school didnt prepare
the Cross Cancer Institute coordinates care for patients me for this the job can be both difficult and inspiring, but its always
from across the country. Providing treatment and help- gratifying, she says. I used to think Id become a teacher, and while
ing patients understand and deal with the unknown of a rare cancer that didnt happen, patient education is an important part of my
work so I think the job is a perdiagnosis is a job not many could keep
up with, but Karey McCann does so with
I think theres still a lot that I can build fect fit for me.
Patients ranging in age
dedication and strength.
into my role here, especially with patient
from newborn to age 90 from
For the past seven years of her
advocacy and education. By the time the across Western Canada come
13-year nursing career, McCann has
been the nuclear medicine therapy trial ends, maybe thats when Ill be ready to the Cross Cancer Instituteto receive one of two types of
and neuroendocrine tumour clinic coto retire, says Karey McCann.
radioisotope therapy lutetium
ordinator at the Cross Cancer Institute,
working with a team of five physicians and one other research nurse. and mIBG both forms of radiation treatment that target specifThe 43-year-old Slave Lake, Alberta native came to her position after ic cells, shutting them down so they cant multiply and divide, and
stints in pediatric oncology at the Stollery Childrens Hospital, as both unlike chemotherapy which attacks healthy and cancerous cells
well as time in several U.S. cities where she was introduced to radio- alike. Lutetium is imported in vials from Holland, where there and
across Europe and Australia the therapy has been regularly used for
isotope therapy.
Then I met Dr. Sandy McEwan, the guru of radioisotope thera- many years.
Still relatively new to North America, lutetium therapy is part of
py in Canada, and Ive been back and part of this amazing program
ever since, McCann says. This year, McCann, who is responsible for a long-term study at the Cross Cancer Institute. Co-ordinated by
co-ordinating and caring for all neuroendocrine patients at the Cross McCann and a colleague, the lutetium clinical trial started in April
Cancer Institute in a program thats a leader in its field across the 2014, aiming to prove the efficacy and safety of radioisotope theracountry, became a CANO Boehringer Ingelheim Oncology Nurse of py over a 15-year period. The trial currently has 97 participants, but
the Year Award nominee. On paper, McCann works a routine-sound- some 400 patients will be part of the program over the term.
40
winter 2014
myleapmagazine.ca
winter 2014
41
WORTH A TRIAL
An Edmonton chemist and her husbands $300,000
donation will fund much needed clinical trials
BY JACQUELINE LOUIE / PHOTO BY DARRYL PROPP
42
winter 2014
myleapmagazine.ca
ill and Charlie Doiron have hope for a better, of $300,000, through the Alberta Cancer Foundation, dihealthier future for breast cancer patients today and rected to the Cross Cancer Institute to fund breast cancer
clinical trials.
in the future.
Youve got a talent pool of medical staff at the Cross
Thats why theyve recently made a major
donation to help fund clinical trials at the Cross Cancer Institute who work very hard, says Charlie. There
Cancer Institute in Edmonton. They want others are a lot of good things being done there using conventional
facing a cancer diagnosis to receive the benefits that Jill did sources of health care funding, which covers current stanfrom the facilitys world class specialists, facilities and dard treatments. Private donations help the Institute to go
beyond the basics to explore the newest treatments and parclinical trials.
In 2001, Jill, then 44, was diagnosed with stage 3C breast ticipate in world-wide clinical trials.
They could have chosen to leave a legacy donation, but
cancer and needed surgery, chemotherapy and radiation.
Statistically, her chances of surviving five years using con- instead opted to make their donation now, so they can see
ventional treatment were not much better than 50:50. the benefits of their commitment. When you donate while
These numbers concerned Jill and Charlie, who both have youre still alive, you get a chance to see your dollars at
science backgrounds. Her medical team helped them work, Jill notes.
Some of it is paying back in gratitude for the benefits
focus on what they could do to improve the odds, so that Jill
weve received from the Cross Cancer Institute but its
would be around see her three young children grow up.
They told me you never know which side of the statistics also a commitment to further the understanding of breast
youll be on, so dont give up, says Jill, who jumped at the cancer and its treatment. Its an investment in our future
opportunity her care team offered her, to participate in a and in our childrens collective futures perhaps a future
worldwide clinical trial studying three different chemother- without breast cancer.
The Doirons generous donation will help make a differapy combinations. Each of the three options was at least
ence in many lives. Its
as good as the best treatment
option available at the time
The Doirons feel its important to a phenomenal and very
donation that
and all had the possibility of begive back to the institution where welcome
will enable us to take the
ing better than the conventional
treatment. One of the drugs Jill benefited from top doctors doing ideas of cancer researchers in Edmonton and
being evaluated in the trial is
leading-edge research into better
bring them to patients
now the current best treatment
treatments for breast cancer.
for testing, says Dr. John
for the type of cancer Jill had,
Mackey, director of the
Charlie says.
For Jill, participating in the clinical trial through the Cross Cancer Institutes clinical trial unit. We know that
Cross Cancer Institute was an easy decision: it meant the patients who go on clinical trials have better outcomes, so
possibility of a better treatment, longer-term followup and I have no doubt these dollars are going to save lives. Clinical
the fact that her participation would help advance scientif- trials are incredibly important, because they bring tomoric knowledge and understanding of new treatments. It had rows cancer treatments to patients today.
Each year, clinical trials at the Cross Cancer Institute althe potential to improve the odds of survival over the stanlow more than 600 people to undergo new treatments that
dard treatment, recalls Jill.
Her journey back to health was not without a few bumps could become state-of-the-art in a few years time. Clinical
in the road, with local cancer recurrences near the surgical trials also allow the Cross Cancer Institute to access drugs
site in 2006 and again in 2011. Each time, she chose to par- that have not yet been approved for use in Canada, even
though we know they are working well, Mackey says. The
ticipate in another clinical trial.
The Doirons, who live in Sherwood Park, firmly believe clinical trials at the Cross Cancer Institute are really the
that access to these clinical trials and the excellent care Jill heart and soul of the institute because clinical trials are
received from the Cross Cancer Institute are factors con- the tool we use to improve our treatments.
Clinical trials are both complex and expensive, Mackey
tributing to why she is alive and thriving today. Im doing
great. We take one day at a time and you develop an attitude says, noting that the Cross Cancer Institutes clinical trial
of gratitude because we really are grateful for the care I re- program is the most active program of its kind in Canada:
more patients per capita participate in clinical trials in Edceived, Jill says.
For his part, Charlie believes that if Jill had not partic- monton than in any other jurisdiction in the country.
The Alberta Cancer Foundation and the money its donors
ipated in the clinical trials at the Cross Cancer Institute,
she might not be here today. They are especially thankful to provide go to support the Cross Cancer Institutes clinical
Dr. Anil Joy, and research nurses Diane Bodnar and Shelley trial program, which helps patients with many different
types of cancer. On top of this funding, the Cross Cancer
Sass, for their amazing advocacy, care and support.
The Doirons feel its important to give back to the Institutes clinical trial unit leverages its core funding from
institution where Jill benefited from top doctors doing the Alberta Cancer Foundation, at a rate of about six to
leading-edge research into better treatments for breast one, with additional dollars from companies and cancer recancer. To this end, theyve made a multi-year commitment searchers from around the world.
winter 2014
43
winter 2014
myleapmagazine.ca
Research Rockstar
46
winter 2014
myleapmagazine.ca
The
Brains
Behind the
Operation
Top neurological cancer researcher
credits his work with keeping him
strong in a trying field
BY NADIA MOHARIB
sk Dr. Gregory Cairncross what motto he lives by and he doesnt really have
an answer.
But chat with the passionate, world-renowned brain cancer researcher for a bit and
its apparent he has honed the fine art of appreciating the little things in life. After
toiling in a relatively dismal area of oncology for about four decades, his outlook is, no doubt,
good medicine for this doctor.
Ive dealt with many disappointments and failures, but I get satisfaction out of the little successes, in the minor victories, not in the big victories because they are so rare, says the director of
the Southern Alberta Cancer Research Institute and University of Calgary researcher.
It also helps that Cairncross divides his time between clinical practice and research, and
the 63-year-old firmly believes the latter is where hope lies in shedding light on the darker aspects
of the job.
How do I cope apart from dreaming about playing golf? What keeps me going is research. Its
the quest to discover something that makes a difference, he says.
winter 2014
47
Research Rockstar
For me, the research career has been an important
way to cope with the repeated disappointment in the
clinic. As Ive gotten older, Im less on the front lines with
patients and that keeps me sheltered a bit from the dayto-day reality. The status quo is the status quo; research is
the only way forward.
On that front, Cairncross is quarterbacking a
national team of researchers at four main laboratories
in Canada, with their headquarters located in Calgary.
Relying on tumour cells
from dozens of glioblastoma
patients, researchers found
a combination of drugs,
including AZD8055 and
Temozolomide already
taken by most glioblastoma patients extended the
life of lab mice by about
30 per cent.
If their laboratory findings hold true in patients, the
discovery could prolong the lives of people with the
aggressive and deadly type of brain cancer which is
diagnosed in about 150 Albertans each year. The findings are poised to go to clinical trial, but given that
most compounds aimed at targeting glioblastomas
fail, Cairncross has learned to curb his enthusiasm
with caution.
We are pleased research has led us to this observation and want to test it in people who have glioblastoma, but time will tell, he says. Its not that Im not
hopeful or excited to do the trial; its just tempered by
30, or 40 years in my case, of experience, where many are called and few are chosen.
True advances are infrequent, progress has been slow.
Over the decades, Cairncrosss commitment to finding breakthroughs in
understanding and treating brain cancer has been steadfast a pivotal point in his
career dates back to 1985 with the curious case of a patient named George.
Georges dramatic response to treatment prompted Cairncross to pursue what
would be his claim to fame the worldwide use of chemotherapy to treat those with
that particular type of cancer, oligodendroglioma. It
also led to the discovery of
molecular features in oligodendroglioma which are
used globally to diagnose and
tailor treatment for those
with the disease. It was a defining moment in my career,
Cairncross says. I spent
the next 30 years studying
Georges kind of cancer and am one of the worlds authorities on that type of cancer.
A few months earlier, his patient was a miserable man battling seizures, headaches
and weakness on one side of his body because of the cancer. But much to Cairncrosss
surprise, treatment melted the tumour away, giving George more time rather than an
imminent death sentence. Ive told that story hundreds of times to colleagues and
students and almost anyone who would listen, says Cairncross, still impressed by the
case. The response was so unexpected and dramatic ... it was so shocking he was better.
The magnitude of the discovery is not lost on Cairncross, either. It would have been
easy for that moment to slip by and not to have really noticed that this was extraordinary. I might have just kind of shrugged my shoulders. Some get a little better, some
dont and on we [usually] go to next patient, he adds. Nature was trying to reveal
itself, and say, This cancer that George has is highly sensitive to the chemotherapy you
are giving.
48
winter 2014
myleapmagazine.ca
ate believer that in order to get great health care we need great science behind it, says
Dr. Jon Meddings, dean of the University of Calgarys faculty of medicine. He practises
what he preaches ... he is a big-picture thinker, he adds.
For now, there is a bitter balance between hope and history for those working in the
field between what might ideally happen and what statistics have shown. The most
difficult thing is seeing a brand-new patient, who, of course, is incredibly hopeful their
illness can be eliminated, Cairncross says.
I dont ever want to take away that hope but of course where Im sitting, I have a different perspective on whats most likely to happen to them, he says. When Im with the patients, I am a glass-half-full person. I will describe how treatment has improved and continues to improve; some people have very good
results with treatment and there is no reason
why a patient shouldnt be one of them.
But he also knows the whole picture. Privately, I dont think anyone is satisfied with the
improvements made to date. My colleagues
want to do much better. The understanding of
the science [behind how the disease works] is
advancing rapidly. The treatment isnt.
Perhaps accepting current limitations of science, Cairncross takes comfort in smaller
victories. Most people who get brain cancers are just minding their own business. Ive
seen my share of sadness and heartbreak, but unfortunately it is a part of life, he says. I
dont take the treatment failure personally; its not my fault the tumour didnt respond.
The occasional patient does spectacularly well and thats a great joy.
Challenging as it might be, the scientist is quick to cite those with more taxing gigs.
Going off to Africa and getting into one of those space suits, looking after Ebola
patients and keeping your fingers crossed you dont get it when it seems like you can
get it fairly easily those doctors are on a much, much more difficult path than
Im on, he says.
winter 2014
49
A Win in Overtime
The play-by-play for a hockey game where the
real goals happen off the ice
Maybe youre tired of writing cheques or signing petitions, and even a bucket of
ice seems tame. Lucky for you, Brent Saik hosts a fundraising hockey game accurately described as primal.
From an NHL-size rink on his acreage near Ardrossan, in 2003 Saik started his tradition of beating the Guinness World Record for the worlds longest hockey game,
which at the time was 82 hours long. In 2011, he and other participants played for
242 hours: more than 10 days non-stop. In 2008, the temperature plummeted to
-51 C and one participant actually lost a toe to frostbite. Its not all missing
appendages, however as the competition increased, so did the fundraising. In 2011,
Saik and the Alberta Cancer Foundation raised $1.3 million, and theyre hoping to
surpass the $2-million mark in February.
Everybody out there has a little bit of competitiveness in them, Saik says.
And who wouldnt, with a crowd of 50,000, including local media personalities in
attendance? For 10 days, legions of spectators will bring their motorhomes to Saiks
property to watch the event, and more than 800 volunteers, from referees to police
officers, will assist.
50
winter 2014
By Robbie Jeffrey
TO EDMONTON ON
REGISTER TODAY
1.855.250.MOVE
BUSTAMOVE.CA
For thirty years, weve been at the foundation of everything from cancer care to cure.
Thank you for helping us make life better for Alberta cancer patients.